David C. Myles
David C. Myles's open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares, price and a link…
Insider buying and selling since 2021
David C. Myles has no open-market purchase on record since 2021. Sales in 3 of the 6 years since 2021.
David C. Myles reported 0 open-market purchases and 12 sales since 2021; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2024 | — | 3×3 trades |
| 2023 | — | 8×8 trades |
| 2021 | — | 1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about David C. Myles's trades
Has David C. Myles bought shares on the open market?
David C. Myles has no open-market purchase on record since 2021. Sales in 3 of the 6 years since 2021.
When did David C. Myles last buy or sell shares?
In SEC filings since 2021: no open-market purchase is on record; the latest open-market sale is from 2024.
Which companies has David C. Myles traded as an insider?
Olema Pharmaceuticals (OLMA), from 2021 to 2024: 0 purchases and 12 sales.